Variant report
Variant | rs4971635 |
---|---|
Chromosome Location | chr2:50250447-50250448 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | STAT3 | chr2:50250389-50250706 | MCF10A-Er-Src | breast: | n/a | chr2:50250577-50250585 |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:50245424..50247273-chr2:50250002..50252375,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NRXN1 | TF binding region |
ENSG00000179915 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1035342 | 0.87[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs12470829 | 0.84[CEU][hapmap] |
rs12478797 | 0.85[CEU][hapmap];0.82[JPT][hapmap] |
rs12713084 | 0.85[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs12987268 | 0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs13013447 | 0.92[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs1363036 | 0.93[CEU][hapmap];1.00[JPT][hapmap] |
rs1369295 | 0.85[CEU][hapmap];0.82[JPT][hapmap] |
rs1421567 | 0.85[CEU][hapmap];0.82[JPT][hapmap] |
rs1421569 | 0.86[CHB][hapmap] |
rs1421577 | 0.85[CEU][hapmap] |
rs1421598 | 0.86[CEU][hapmap];0.86[CHB][hapmap] |
rs1469003 | 0.85[CEU][hapmap];1.00[JPT][hapmap] |
rs1477248 | 0.85[CEU][hapmap] |
rs1477249 | 0.85[CEU][hapmap];0.82[JPT][hapmap] |
rs1541642 | 0.85[CEU][hapmap];0.82[JPT][hapmap] |
rs1592728 | 0.91[CEU][hapmap];0.84[CHB][hapmap];1.00[JPT][hapmap] |
rs1819972 | 0.87[ASN][1000 genomes] |
rs1895130 | 0.91[ASN][1000 genomes] |
rs1895131 | 0.91[ASN][1000 genomes] |
rs2351149 | 0.82[CEU][hapmap];1.00[JPT][hapmap] |
rs2351152 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs2351153 | 0.89[ASN][1000 genomes] |
rs2859977 | 0.85[CEU][hapmap];1.00[JPT][hapmap] |
rs4583505 | 1.00[CEU][hapmap];0.82[CHB][hapmap] |
rs4971632 | 0.85[CEU][hapmap];1.00[JPT][hapmap] |
rs4971634 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs4971636 | 0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs4971639 | 0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs4971640 | 0.91[ASN][1000 genomes] |
rs6545137 | 0.85[CEU][hapmap];0.82[JPT][hapmap] |
rs6545144 | 0.86[CHB][hapmap];1.00[JPT][hapmap] |
rs6545145 | 0.84[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6706484 | 0.85[CEU][hapmap];0.82[JPT][hapmap] |
rs6706613 | 0.85[CEU][hapmap];0.82[JPT][hapmap] |
rs6712956 | 1.00[CEU][hapmap];1.00[JPT][hapmap] |
rs6712970 | 0.95[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs6714990 | 0.85[CEU][hapmap];0.82[JPT][hapmap] |
rs6736816 | 0.92[ASN][1000 genomes] |
rs6746395 | 0.87[EUR][1000 genomes] |
rs6754803 | 0.80[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs6761463 | 0.82[JPT][hapmap] |
rs7596020 | 0.83[CEU][hapmap];0.82[JPT][hapmap] |
rs7601845 | 0.91[ASN][1000 genomes] |
rs930295 | 0.85[CEU][hapmap];1.00[JPT][hapmap] |
rs9309173 | 0.91[ASN][1000 genomes] |
rs9636391 | 0.82[JPT][hapmap] |
rs980794 | 0.85[CEU][hapmap];1.00[JPT][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv3388948 | chr2:50092667-50602681 | Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Strong transcription | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 4 gene(s) | inside rSNPs | diseases |
2 | esv3399511 | chr2:50092687-50602651 | Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Strong transcription | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 4 gene(s) | inside rSNPs | diseases |
3 | nsv934303 | chr2:50145598-50412189 | Bivalent Enhancer Enhancers Active TSS Weak transcription ZNF genes & repeats Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 2 gene(s) | inside rSNPs | diseases |
4 | nsv581837 | chr2:50230334-50268616 | Weak transcription Flanking Active TSS Enhancers | TF binding regionCpG islandChromatin interactive region | 1 gene(s) | inside rSNPs | diseases |
5 | nsv1011144 | chr2:50231111-50270096 | Enhancers Flanking Active TSS Weak transcription | TF binding regionCpG islandChromatin interactive region | 1 gene(s) | inside rSNPs | diseases |
6 | nsv915588 | chr2:50235306-50268306 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | inside rSNPs | diseases |
7 | nsv431002 | chr2:50243349-50259749 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | inside rSNPs | diseases |
8 | nsv1004550 | chr2:50250335-50274067 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50250000-50250800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr2:50250400-50252200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |